Matches in Wikidata for { <http://www.wikidata.org/entity/Q95336729> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q95336729 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95336729 description "scientific article published on 18 May 2020" @default.
- Q95336729 description "wetenschappelijk artikel" @default.
- Q95336729 description "наукова стаття, опублікована 18 травня 2020" @default.
- Q95336729 name "Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22-positive B-cell acute lymphoblastic leukaemia" @default.
- Q95336729 name "Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22-positive B-cell acute lymphoblastic leukaemia" @default.
- Q95336729 type Item @default.
- Q95336729 label "Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22-positive B-cell acute lymphoblastic leukaemia" @default.
- Q95336729 label "Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22-positive B-cell acute lymphoblastic leukaemia" @default.
- Q95336729 prefLabel "Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22-positive B-cell acute lymphoblastic leukaemia" @default.
- Q95336729 prefLabel "Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22-positive B-cell acute lymphoblastic leukaemia" @default.
- Q95336729 P1433 Q95336729-B661F6B4-0678-4935-8873-6247DD1F9743 @default.
- Q95336729 P1476 Q95336729-53248E19-B3C2-4D81-B790-6F03AEC19070 @default.
- Q95336729 P2093 Q95336729-03BB1F90-294B-4E99-BD2F-645D9C54D2AA @default.
- Q95336729 P2093 Q95336729-093A19DD-55DA-4887-A537-1F8A8D94610E @default.
- Q95336729 P2093 Q95336729-2C0A1E08-2C55-4891-BD23-6E3EB9AE6D2E @default.
- Q95336729 P2093 Q95336729-341BBF0E-0945-4A7D-BB19-0A3D39D7EA40 @default.
- Q95336729 P2093 Q95336729-8857C720-B843-4887-B269-C4E1F0EB07ED @default.
- Q95336729 P2093 Q95336729-BB29F532-5ED2-4AB1-87B0-7F75ED09FD87 @default.
- Q95336729 P2093 Q95336729-DAC26A45-511E-4078-BFD9-286EF4C3578E @default.
- Q95336729 P2093 Q95336729-DB4B772C-C181-4C30-8E9E-BE6D0675709D @default.
- Q95336729 P2093 Q95336729-E6BAB0AC-A053-413F-8F26-83423E8A04CC @default.
- Q95336729 P31 Q95336729-C23CD95E-0BC2-4DF1-8249-9F8AB3710A58 @default.
- Q95336729 P356 Q95336729-8D559EF7-8EA5-44BB-AC91-9E28C99D1ABA @default.
- Q95336729 P50 Q95336729-1A3D1ACB-85BA-41A5-8878-CD07D555D9CC @default.
- Q95336729 P50 Q95336729-72DB61E7-F2BB-4895-910B-C8E7F6FEA276 @default.
- Q95336729 P577 Q95336729-0A0270C8-D6F8-413E-A5A9-175189C53DCD @default.
- Q95336729 P698 Q95336729-4EC736F1-0763-41A3-AA28-6846235E56F2 @default.
- Q95336729 P921 Q95336729-35627A1A-95F5-416C-B5E8-6AC2D8756E97 @default.
- Q95336729 P356 BJH.16732 @default.
- Q95336729 P698 32424837 @default.
- Q95336729 P1433 Q4970200 @default.
- Q95336729 P1476 "Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22-positive B-cell acute lymphoblastic leukaemia" @default.
- Q95336729 P2093 "André Baruchel" @default.
- Q95336729 P2093 "Benoit Brethon" @default.
- Q95336729 P2093 "Bénédicte Bruno" @default.
- Q95336729 P2093 "Dalila Adjaoud" @default.
- Q95336729 P2093 "Geneviève Willson-Plat" @default.
- Q95336729 P2093 "Juliette Villemonteix" @default.
- Q95336729 P2093 "Laurence Blanc" @default.
- Q95336729 P2093 "Marie-Dominique Tabone" @default.
- Q95336729 P2093 "Nicolas Boissel" @default.
- Q95336729 P31 Q13442814 @default.
- Q95336729 P356 "10.1111/BJH.16732" @default.
- Q95336729 P50 Q91915658 @default.
- Q95336729 P50 Q92917452 @default.
- Q95336729 P577 "2020-05-18T00:00:00Z" @default.
- Q95336729 P698 "32424837" @default.
- Q95336729 P921 Q407954 @default.